ConductScience.org, home

Paper42579369

Combined FAK and MEK inhibition suppresses chromosome 8 gain malignant peripheral nerve sheath tumors.

Wang G and 17 others. J Clin Invest, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Combined FAK and MEK inhibition suppresses chromosome 8 gain malignant peripheral nerve sheath tumors. Papers, record 42579369. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42579369

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Combined FAK and MEK inhibition suppresses chromosome 8 gain malignant peripheral nerve sheath tumors.
PubMed
Journal
J Clin Invest
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-10-03
PubMed

Authors18

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang GGuangfeng
2Borcherding DCDana C
3Wang JJiawan
4Zhang XXiaochun
5Yang LLiuzhan
6Oztosun GGorkem
7Sears JJJames J
8Xiao KKangwen
9Garana BBBelinda B
10Zoberi MIMark I
11Bektas AUAaron U
12Szymanski JJJeffrey J
13Rathore RRicha
14Coma SSilvia
15Pachter JAJonathan A
16Gosline SJSara Jc
17Pratilas CAChristine A
18Hirbe ACAngela C

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Focal Adhesion Kinase 1Major topic
Chromosomes, Human, Pair 8Major topic
Protein Kinase InhibitorsMajor topic
Nerve Sheath NeoplasmsMajor topic
Neoplasm ProteinsMajor topic
NeurofibrosarcomaMajor topic
Humans
Animals
Mice
Cell Line, Tumor
Female

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 CA091842NCI NIH HHSUnited StatesP30CA091842PubMedNIH RePORTER
R01 NS134815NINDS NIH HHSUnited StatesR01NS134815PubMedNIH RePORTER

Download CSV of grants

References77

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132493400FAK activates AKT-mTOR signaling to promote the growth and progression of MMTV-Wnt1-driven basal-like mammary tumors.Breast Cancer Res2020https://conductscience.org/library/papers/32493400PubMed
239375168
GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator's choice of treatment in patients with recurrent low grade serous ovarian cancer.
Int J Gynecol Cancer2025https://conductscience.org/library/papers/39375168PubMed
325062113Neurofibromatosis type 1 (NF1) and associated tumors.Klin Padiatr2014https://conductscience.org/library/papers/25062113PubMed
431285952Glutathione reductase (GSR) gene deletion and chromosome 8 aneuploidy in primary lung cancers detected by fluorescence in situ hybridization.Am J Cancer Res2019https://conductscience.org/library/papers/31285952PubMed
535875109Preclinical Assessment of MEK Inhibitors for Malignant Peripheral Nerve Sheath Tumors Reveals Differences in Efficacy and Adaptive Response.Front Oncol2022https://conductscience.org/library/papers/35875109PubMed
624861215Fibroblastic growth factor receptor 1 amplification in osteosarcoma is associated with poor response to neo-adjuvant chemotherapy.Cancer Med2014https://conductscience.org/library/papers/24861215PubMed
711526219Human mitochondrial topoisomerase I.Proc Natl Acad Sci U S A2001https://conductscience.org/library/papers/11526219PubMed
838954182Malignant Peripheral Nerve Sheath Tumor, a Heterogeneous, Aggressive Cancer with Diverse Biomarkers and No Targeted Standard of Care: Review of the Literature and Ongoing Investigational Agents.Target Oncol2024https://conductscience.org/library/papers/38954182PubMed
919479903Neurofibromin physically interacts with the N-terminal domain of focal adhesion kinase.Mol Carcinog2009https://conductscience.org/library/papers/19479903PubMed
1024746704Disruption of CRAF-mediated MEK activation is required for effective MEK inhibition in KRAS mutant tumors.Cancer Cell2014https://conductscience.org/library/papers/24746704PubMed
1123221341MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors.J Clin Invest2013https://conductscience.org/library/papers/23221341PubMed
1233171331Regulation of PD-L1 expression in K-ras-driven cancers through ROS-mediated FGFR1 signaling.Redox Biol2021https://conductscience.org/library/papers/33171331PubMed
1332975370Functional imaging of RAS pathway targeting in malignant peripheral nerve sheath tumor cells and xenografts.Pediatr Blood Cancer2020https://conductscience.org/library/papers/32975370PubMed
1435446392The Need for New Treatments Targeting MPNST: The Potential of Strategies Combining MEK Inhibitors with Antiangiogenic Agents.Clin Cancer Res2022https://conductscience.org/library/papers/35446392PubMed
1529117388Neurofibromatosis Type 1-Associated MPNST State of the Science: Outlining a Research Agenda for the Future.J Natl Cancer Inst2017https://conductscience.org/library/papers/29117388PubMed
1634405004PSD3 is an oncogene that promotes proliferation, migration, invasion, and G1/S transition while inhibits apoptotic in papillary thyroid cancer.J Cancer2021https://conductscience.org/library/papers/34405004PubMed
1727036135Proteomic Profiling Identifies PTK2/FAK as a Driver of Radioresistance in HPV-negative Head and Neck Cancer.Clin Cancer Res2016https://conductscience.org/library/papers/27036135PubMed
1829138631SARC006: Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated Chemotherapy-Naive Malignant Peripheral Nerve Sheath Tumors.Sarcoma2017https://conductscience.org/library/papers/29138631PubMed
1938822146Epithelial-mesenchymal transition status is a remarkable biomarker for the combination treatment with avutometinib and defactinib in KRAS-mutated non-small cell lung cancer.Br J Cancer2024https://conductscience.org/library/papers/38822146PubMed
2032642731Diagnosis and management of malignant peripheral nerve sheath tumors: Current practice and future perspectives.Neurooncol Adv2020https://conductscience.org/library/papers/32642731PubMed

See all 77 referencesDownload CSV of references

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42579369

GET https://conductscience.org/api/papers/v1/42579369/references?page=2